ロード中...
High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli
BACKGROUND: Suboptimal clinical response to fluoroquinolone (FQ) therapy has been clearly documented in patients with Salmonella typhi infection with reduced FQ susceptibility. However, the clinical impact of reduced FQ susceptibility on other infections including E. coli urinary tract infections (U...
保存先:
| 出版年: | Ann Clin Microbiol Antimicrob |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5385084/ https://ncbi.nlm.nih.gov/pubmed/28390438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-017-0202-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|